127 related articles for article (PubMed ID: 37767910)
1. Therapeutic drug monitoring of methotrexate in patients with Crohn's disease.
van de Meeberg MM; Fidder HH; Oldenburg B; Sundaresan J; Struys EA; Montazeri NSM; Mares WGN; Mahmmod N; van Asseldonk DP; Lutgens MWMD; Kuyvenhoven JP; Rietdijk ST; Nissen LHC; Koehestanie P; de Boer NKH; de Jonge R; Bouma G; Bulatović Ćalasan M;
Aliment Pharmacol Ther; 2023 Dec; 58(11-12):1151-1162. PubMed ID: 37767910
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous administration, higher age and lower renal function are associated with erythrocyte methotrexate accumulation in Crohn's disease: a cross-sectional study.
van de Meeberg MM; Seinen ML; Fidder HH; Lin M; Oldenburg B; de Boer NK; Bouma G; de Jonge R; Bulatović Ćalasan M;
BMC Gastroenterol; 2022 Jul; 22(1):365. PubMed ID: 35907797
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study.
Haisma SM; Lijftogt T; Kindermann A; Damen G; de Ridder L; Escher JC; Mearin ML; de Meij T; Hendriks D; George E; Hummel T; Norbruis O; van Rheenen P
J Crohns Colitis; 2015 Apr; 9(4):305-11. PubMed ID: 25656249
[TBL] [Abstract][Full Text] [Related]
4. Adverse effects related to methotrexate polyglutamate levels: adjudicated results from the cardiovascular inflammation reduction trial.
Xu C; Selhub J; Jacques P; Paynter NP; MacFadyen JG; Glynn RJ; Ridker PM; Solomon DH
Rheumatology (Oxford); 2021 Jun; 60(6):2963-2968. PubMed ID: 34144603
[TBL] [Abstract][Full Text] [Related]
5. Determinants of erythrocyte methotrexate polyglutamate levels in rheumatoid arthritis.
den Boer E; de Rotte MC; Pluijm SM; Heil SG; Hazes JM; de Jonge R
J Rheumatol; 2014 Nov; 41(11):2167-78. PubMed ID: 25225283
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis.
van de Meeberg MM; Hebing RCF; Nurmohamed MT; Fidder HH; Heymans MW; Bouma G; de Bruin-Weller MS; Tekstra J; van den Bemt B; de Jonge R; Bulatović Ćalasan M
Br J Clin Pharmacol; 2023 Jan; 89(1):61-79. PubMed ID: 36326810
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study.
Uhlen S; Belbouab R; Narebski K; Goulet O; Schmitz J; Cézard JP; Turck D; Ruemmele FM
Inflamm Bowel Dis; 2006 Nov; 12(11):1053-7. PubMed ID: 17075346
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate Polyglutamates Exposure - Response Modeling in a Large Cohort of Rheumatoid Arthritis Patients Starting Methotrexate.
Hebing RCF; Bartelink IH; Gosselt HR; Heil SG; de Rotte MCFJ; de Jong PHP; Nurmohamed MT; de Jonge R; Mathôt RAA
Clin Pharmacol Ther; 2023 Oct; 114(4):893-903. PubMed ID: 37313979
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in juvenile idiopathic arthritis patients.
Ćalasan MB; den Boer E; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
Ann Rheum Dis; 2015 Feb; 74(2):402-7. PubMed ID: 24288013
[TBL] [Abstract][Full Text] [Related]
10. Correlation between serum methotrexate-polyglutamate 3 (MTX-PG3) level and disease activity in rheumatoid arthritis patients: A prospective cohort study.
Musdalita E; Hidayat R; Sumariyono S; Kusumo Wibowo SA; Ariane A; Shatri H; Rengganis I; Antono D
F1000Res; 2022; 11():187. PubMed ID: 35284067
[No Abstract] [Full Text] [Related]
11. Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial.
Hebing RC; Lin M; Bulatovic Calasan M; Muller IB; Mahmoud S; Heil S; Struys EA; van den Bemt BJ; Twisk JW; Lems W; Nurmohamed MT; Jansen G; de Jonge R
Ann Rheum Dis; 2023 Apr; 82(4):460-467. PubMed ID: 36543526
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate Polyglutamate Monitoring in Patients With Crohn's Disease.
Fischer M; Siva S; Cook GK; Jones DR; Fadda HM
Clin Pharmacol Drug Dev; 2017 May; 6(3):240-245. PubMed ID: 27274011
[TBL] [Abstract][Full Text] [Related]
13. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
Nathan DM; Iser JH; Gibson PR
J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
[TBL] [Abstract][Full Text] [Related]
14. European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysis.
Kopylov U; Katsanos KH; van der Woude CJ; Karmiris K; Hernandez V; Odes S; Papamichael K; Koutroubakis IE; Bojic D; Kaimakliotis I; Fiorino G; Papageorgiou N; Pineda JR; Strongili K; Sanroman L; Mantzaris GJ; Jojic N; Paspatis G; Christodoulou DK; Ben-Horin S; Tsianos EV
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):802-6. PubMed ID: 26894634
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial.
Goss SL; Klein CE; Jin Z; Locke CS; Rodila RC; Kupper H; Burmester GR; Awni WM
Clin Ther; 2018 Feb; 40(2):309-319. PubMed ID: 29402521
[TBL] [Abstract][Full Text] [Related]
16. [The efficacy and safety of methotrexate in refractory Crohn's disease].
Xu P; He Y; Chen Y; Chao K; Chen B; Mao R; Tang R; Zhu Z; Zeng Z; Chen M
Zhonghua Nei Ke Za Zhi; 2014 Mar; 53(3):188-92. PubMed ID: 24767205
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate for treating rheumatoid arthritis.
Lopez-Olivo MA; Siddhanamatha HR; Shea B; Tugwell P; Wells GA; Suarez-Almazor ME
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD000957. PubMed ID: 24916606
[TBL] [Abstract][Full Text] [Related]
18. [Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate].
Hafraoui S; Dewit O; Marteau P; Cosnes J; Colombel JF; Modigliani R; Cortot A; Lémann M
Gastroenterol Clin Biol; 2002 Jan; 26(1):17-22. PubMed ID: 11938035
[TBL] [Abstract][Full Text] [Related]
19. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
20. Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course.
Harris RE; Aloi M; de Ridder L; Croft NM; Koletzko S; Levine A; Turner D; Veereman G; Neyt M; Bigot L; Ruemmele FM; Russell RK;
BMJ Open; 2020 Jul; 10(7):e034892. PubMed ID: 32611737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
